Daicel Corporation

4202.T
Specialty Chemicals
2026/08/23 Updated
Market Cap: $2.4B (¥374.5B)
Stock Price: $9.22 (¥1,466)
Exchange Rate: 1 USD = ¥158.98

Detailed Explanation of the 2026 Mid-Term Management Plan and Business Strategy|May 2026

Daicel is advancing its business restructuring, new business initiatives, and corporate reforms based on the 2026 mid-term management plan, aiming for revenue and profit growth and maximizing capital efficiency.

Importance:
Page Updated: May 22, 2026
IR Disclosure Date: May 22, 2026

Key Figures

  • Sales Revenue: Unknown
  • Operating Profit: Unknown
  • EBITDA: Unknown

AI要約

Future Outlook and Key Initiatives

Daicel aims to expand sales revenue to approximately 675 billion yen by 2028, about 1.4 times the current level, and to improve EBITDA and operating profit margins. Key initiatives include product line rationalization, promotion of local production for local consumption, manufacturing process improvements, expansion into electronic devices and high value-added products, and strengthening overseas expansion. In particular, by consolidating product lines and promoting local production for local consumption, the company seeks to reduce costs and enhance profitability, thereby strengthening the business’s earnings foundation.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daicel Corporation

Company overview · Stock price · Financial data · All IR

View company page →